Heartseed Inc. announced that it expects to receive funding from Gene Techno Science Co.,Ltd., Nissay Capital Co.,Ltd, SBI Investment Co., Ltd., JMDC Inc., Astellas Venture Management LLC
August 29, 2019
Share
Heartseed Inc. announced that it will receive an equity round of funding on August 30, 2019.
On the same day, the company has received funding in its first tranche. The tranche included participation form new investorsGene Techno Science Co.,Ltd. (TSE:4584) and Nissay Capital No. 9 Investment Limited Partnership, a fund managed by Nissay Capital Co.,Ltd.
JMDC Inc. is a Japan-based company mainly engaged in the health big data business, telemedicine business and dispensing pharmacy support business. The Company operates in three business segments. The Health Big Data segment is engaged in the provision of receipt data analysis and health promotion solutions, and personal health information platforms, the build, management and analysis of medical databases such as receipt data and medical examination data, the build and sale of drug databases, and the development and provision of systems using drug databases for medical institutions. The Telemedicine segment is engaged in the provision of remote image diagnosis matching services, and infrastructure systems for remote image diagnosis. The Dispensing Pharmacy Support segment is engaged in the development and provision of business systems and electronic medication record for dispensing pharmacies, as well as the operation of dispensing pharmacies.
Heartseed Inc. announced that it expects to receive funding from Gene Techno Science Co.,Ltd., Nissay Capital Co.,Ltd, SBI Investment Co., Ltd., JMDC Inc., Astellas Venture Management LLC
JMDC INC. 
